Roivant/Roche: Did Pfizer Miss Out?

Merck/Prometheus Deal Changed TL1A Market Dynamics

 
• By Jessica Merrill
  
question mark
Pfizer's deal with Roivant raises questions • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business